Q4 2014 Holdings
Filed 2015-02-17 | 6 holdings | $126.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-05-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| T2 Biosystems, Inc.A | Common Stock | 89853L104 | $45.7K | 2,374,571 | 36.1% |
| Trevena, Inc. | Common Stock | 89532E109 | $22.5K | 3,769,280 | 17.8% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $20.4K | 3,287,529 | 16.2% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $14.4K | 2,055,230 | 11.4% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $12.4K | 2,473,186 | 9.8% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $10.9K | 2,018,253 | 8.6% |